1 Introduction
Endometriosis is a chronic gynecological disorder characterized by endometrial tissue outside the uterus and affects 10–15 % of women in reproductive age.1–4 Endometriosis contributes a lot to pelvic pain, ovarian mass, and infertility.1,5 In addition, adenomyosis, which is known as “endometriosis of the uterus”, an important gynecological disorder and causes severe pelvic pain6,7, but their interrelations is not fully understood.6 Immunological disorder, angiogenesis and endocrine are closely related to the development of endometriosis. H.Kobayashi has reported that Neurotrophins (NTs) are overexpressed in endometriosis and encompass nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and NT-3 and NT-4/5, An increased release of proinflammatory cytokines from endometriotic lesions is contribute to the excessive sensory innervation and development of chronic pelvic pain8. Immune system dysfunction greatly impacts the development of endometriosis, which involves various types of immune cells and cytokines.1,9 The feature of the host immunity is also closely related to bacterial vaginosis (BV),10 previous studies had demonstrated that infection of the genital tract might be associated with endometriosis, lipopolysaccharide regulates the pro-inflammatory response and the growth of endometriosis through the LPS/TLR4 cascade. Besides, the cross-talk between inflammation and ovarian steroids or the stress reaction also was observed in the pelvic peritoneum.11,12 Menstrual cycle-related taxa are over-represented in endometriosis and adenomyosis patients.13
Bacterial vaginosis (BV) is best described as a polybacterial dysbiosis,14 and it is correlated to immune dysfunction.15,16 Numbers of evidence suggested that endometriosis was associated with bacterial infection and lipopolysaccharide.10,16,17 The related bacteria may rise from the vaginal to the uterine cavity, but the exact mechanism is still unrevealed. Human Microbiome Project (HMP) is aimed to recognize the importance of bacterial community in human health.17 Since the 16s-ribosome RNA sequencing technology was developed, much more bacteria were identified because culture-based technology can only culture finite live bacteria while approximately 1 % of bacteria can be culture.18 HMP project had been conducted in many different aspects, including urine, fetal-amniotic fluid-maternal host, digestion tract, and human skin17–24. Some researchers even performed the gut microbiome analysis in endometriosis mice25; however, there is only a few studies on the microbiome of endometriosis or adenomyosis in the female genital tract. Chen et al. conducted the random forest models distinguished depletion or enrichment of many bacteria subjected to diseases.13 The results were relatively debatable for those who had previously demonstrated the possible microbiome features in endometriosis patients. A large cohort study had revealed that BV is positively correlated to endometriosis,26 but the BV-related Atopobium was found depletion.27
It is important to investigate the microbiome in endometriosis and adenomyosis patients. We can alleviate endometriosis by regulating vaginal bacterial if the exact functions of the microbiome are identified in the future.